AGP Picks
View all

AGP Executive Report

Last update: 12 hours ago

Pancreatic Cancer: The European Commission has authorised Rasonque for adults with metastatic pancreatic cancer after at least one prior systemic treatment. The approval covers Liechtenstein, but patient access will depend on local pricing and reimbursement. Ovarian Cancer: Sepalna has won European approval as maintenance therapy after first-line chemotherapy for certain patients with advanced ovarian, fallopian tube or peritoneal cancer; Liechtenstein is among the markets covered by its regional rights. Short Bowel Syndrome: The EU has approved Zeydovio, a twice-weekly treatment for adults with short bowel syndrome, marking the first major European treatment advance for the condition in more than a decade. Respiratory Health: EU advisers recommend expanding Merck’s RSV prevention treatment to protect some high-risk children through a second season. The European Commission is expected to decide within two months; the proposed coverage includes Liechtenstein.

Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.

AGP Wire

fallback image
Nov. 3, 2026

Genki relaunches Native with month-to-month global health insurance

AGP

fallback image
Sep. 7, 2026

Swiss parabolic flight campaign pivots toward commercial space applications

AGP

fallback image
Jul. 3, 2026

European Commission authorizes CinnaGen’s osteoporosis biosimilar Zandoriah in EU

AGP

fallback image
Jul. 28, 2026

The European releases its Summer 2026 edition

AGP


Perspectify logo Perspectify News

Learn about labels.

Labels
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate Press Release Service
filter

Filter

Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Press Release Service
Revolution Medicines’ Rasonque gains EC authorisation for pancreatic cancer

Revolution Medicines’ Rasonque gains EC authorisation for pancreatic cancer

From "Healthspans" To Blockchain – A Report From Apex Invest Europe Conference

From "Healthspans" To Blockchain – A Report From Apex Invest Europe Conference

Investigation launched as first human case of 'brain disease' found in EU country popular with UK tourists

Investigation launched as first human case of 'brain disease' found in EU country popular with UK tourists

Von der Leyen confident all EU members will back €45bn loan for Ukraine

Von der Leyen confident all EU members will back €45bn loan for Ukraine


fallback image
Nov. 16, 2026

European Commission Approves Revolution Medicines’ RASONQUE® (daraxonrasib), the First Broad RAS-Targeted Medicine in Metastatic Pancreatic Cancer

GlobeNewswire, Inc.

fallback image
Nov. 13, 2026

Zealand Pharma announces EU approval of Zeydovio™ (glepaglutide) for the treatment of short bowel syndrome

GlobeNewswire, Inc.

fallback image
Nov. 3, 2026

Genki Relaunches Health Insurance for Nomads

EIN Presswire

fallback image
Oct. 23, 2026

SERB Pharmaceuticals Announces Positive Results from the Post-Authorisation Efficacy Study of Idefirix® (imlifidase) Presented at ASN Kidney Week 2026

GlobeNewswire, Inc.

fallback image
Oct. 15, 2026

Revolution Medicines’ RASONQUE(™) (daraxonrasib) Receives Positive CHMP Opinion Recommending Marketing Authorization in European Union for Metastatic Pancreatic Cancer

GlobeNewswire, Inc.

fallback image
Sep. 25, 2026

European Commission grants marketing authorisation for NEZGLYAL® (leriglitazone), the first pharmacological treatment approved for cerebral Adrenoleukodystrophy (cALD), a rare neurodegenerative disease

GlobeNewswire, Inc.

More press releases

Video Stories

YouTube video thumbnail: Is Europe Ready for Undersea Sabotage?
Play
Is Europe Ready for Undersea Sabotage?
YouTube video thumbnail: What’s at Stake in Europe’s Data Centre Expansion?
Play
What’s at Stake in Europe’s Data Centre Expansion?
YouTube video thumbnail: Discover Affinity Group Publishing
Play
Discover Affinity Group Publishing
YouTube video thumbnail: UK and EU: Is six Years After a Divorce a Good Time to get Back Together?
Play
UK and EU: Is six Years After a Divorce a Good Time to get Back Together?
YouTube video thumbnail: Could Attacks on Ukraine's Power Grid Trigger a Nuclear Disaster?
Play
Could Attacks on Ukraine's Power Grid Trigger a Nuclear Disaster?

Video Title

Sign up for:

Health Monitor Liechtenstein

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

globe

Explore More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health Monitor Liechtenstein

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.